MARIE TOBIANSKI: Open Payments
NPI 1114541786 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,438 in 27 payments from 7 companies in 2025. Trend: 2023 $165 · 2024 $844 · 2025 $2,438
Food & beverage: $1,579Travel & lodging: $859
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 13 | $1,512 |
| ABIOMED | 5 | $291 |
| Edwards Lifesciences Corporation | 2 | $262 |
| Medtronic, Inc. | 2 | $168 |
| PFIZER INC. | 1 | $126 |
| Boston Scientific Corporation | 3 | $55 |
| Merck Sharp & Dohme LLC | 1 | $25 |
Products named: NAVITOR, SAPIEN 3 Ultra RESILIA, 2ND GEN CENTRIMAG PRIMARY CONSOLE, SYMPLICITY G3, ELIQUIS, WATCHMAN FLX, COREVALVE EVOLUT R, WINREVAIR.
Industry payments across WA — which companies pay providers there.
